Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
IMAB similar filings
- 29 Mar 22 Financial results demonstrate strong fundamentals
- 4 Mar 22 I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific
- 22 Feb 22 Current report (foreign)
- 28 Jan 22 I-Mab’s Announcement on Unusual Price Movement
- 21 Dec 21 I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization
- 15 Dec 21 I-Mab Presents Interim Clinical Data of Lemzoparlimab in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin Lymphoma at ASH 2021
- 10 Dec 21 Current report (foreign)
Filing view
External links